BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24001613)

  • 1. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
    Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P
    Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
    Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
    Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
    Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
    Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
    Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of LY294002 on adriamycin-induced epithelial-mesenchymal transition in human breast carcinoma cells.
    Qian YJ; Cheng XM; Wang B; Xu L; Wu CJ; Zhao ML; Qi XH; Guo J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):319-23. PubMed ID: 22954111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
    Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
    Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J
    Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 splicing variant IL-7δ5 induces EMT and metastasis of human breast cancer cell lines MCF-7 and BT-20 through activation of PI3K/Akt pathway.
    Yang J; Zeng Z; Peng Y; Chen J; Pan L; Pan D
    Histochem Cell Biol; 2014 Oct; 142(4):401-10. PubMed ID: 24770666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
    Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
    J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.